Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2021

Dec 31, 2021

32227_dirs_2021-12-30_749301a5-aada-441f-aa51-f3235d93a729.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-12-30

Reporting Person: Wallar Gina M (President, Pharma Services)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-30 Common Stock A 15286 Acquired 21299 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $9.22 2023-04-19 Common Stock (6667.0) 6667 Direct
Stock Option (Right to Buy) $13.87 2023-12-12 Common Stock (8334.0) 8334 Direct
Stock Option (Right to Buy) $20.83 2026-05-01 Common Stock (7153.0) 7153 Direct
Stock Option (Right to Buy) $27.34 2027-05-01 Common Stock (7879.0) 7879 Direct
Stock Option (Right to Buy) $48.99 2028-05-01 Common Stock (8595.0) 8595 Direct
Stock Option (Right to Buy) $43.95 2028-07-05 Common Stock (10126.0) 10126 Direct

Footnotes

F1: On December 30, 2021, Ms. Wallar was granted 15,286 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.

F2: On April 19, 2018, Ms. Wallar was granted 20,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.

F3: On December 12, 2018, Ms. Wallar was granted 25,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.

F4: On May 1, 2019, Ms. Wallar was granted 9,537 stock options. The options vest ratably over the first four anniversary dates of the grant date.

F5: On May 1, 2020, Ms. Wallar was granted 7,879 stock options. The options vest ratably over the first four anniversary dates of the grant date.

F6: On May 1, 2021, Ms. Wallar was granted 8,595 stock options. The options vest ratably over the first four anniversary dates of the grant date.

F7: On July 5, 2021, Ms. Wallar was granted 10,126 stock options. The options vest ratably over the first four anniversary dates of the grant date.